GlaxoSmithKline plc (GSK) Receives Average Rating of “Hold” from Brokerages
Shares of GlaxoSmithKline plc (LON:GSK) have received an average rating of “Hold” from the twenty-two brokerages that are covering the company, MarketBeat.com reports. Four research analysts have rated the stock with a sell rating, ten have assigned a hold rating and eight have assigned a buy rating to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is GBX 1,715.20 ($22.18).
A number of analysts recently issued reports on the stock. Berenberg Bank upgraded shares of GlaxoSmithKline plc from a “hold” rating to a “buy” rating and raised their price objective for the stock from GBX 1,850 ($23.93) to GBX 1,885 ($24.38) in a report on Friday, May 26th. Liberum Capital restated a “buy” rating and set a GBX 1,900 ($24.57) price objective on shares of GlaxoSmithKline plc in a report on Thursday, July 27th. Goldman Sachs Group, Inc. (The) set a GBX 1,900 ($24.57) price objective on shares of GlaxoSmithKline plc and gave the stock a “buy” rating in a report on Wednesday, July 26th. Jefferies Group LLC raised their price objective on shares of GlaxoSmithKline plc from GBX 1,800 ($23.28) to GBX 1,900 ($24.57) and gave the stock a “buy” rating in a report on Friday, June 16th. Finally, Barclays PLC restated an “equal weight” rating and set a GBX 1,550 ($20.05) price objective on shares of GlaxoSmithKline plc in a report on Thursday, July 27th.
Shares of GlaxoSmithKline plc (LON:GSK) traded down 0.23% during midday trading on Wednesday, hitting GBX 1519.50. GlaxoSmithKline plc has a 12-month low of GBX 1,446.50 and a 12-month high of GBX 1,745.56. The stock’s market capitalization is GBX 74.27 billion. The company’s 50 day moving average price is GBX 1,546.43 and its 200-day moving average price is GBX 1,621.42.
The company also recently disclosed a dividend, which will be paid on Thursday, October 12th. Stockholders of record on Thursday, August 10th will be given a GBX 19 ($0.25) dividend. The ex-dividend date is Thursday, August 10th. This represents a dividend yield of 1.23%.
In related news, insider Patrick Vallance bought 861 shares of the company’s stock in a transaction on Friday, July 14th. The stock was acquired at an average cost of GBX 1,618 ($20.93) per share, for a total transaction of £13,930.98 ($18,017.30). Also, insider Manvinder Singh Banga bought 2,267 shares of the company’s stock in a transaction on Wednesday, July 26th. The shares were bought at an average price of GBX 1,599 ($20.68) per share, with a total value of £36,249.33 ($46,882.22). Insiders bought 3,151 shares of company stock valued at $5,054,922 over the last 90 days.
About GlaxoSmithKline plc
GlaxoSmithKline plc is a global healthcare company. The Company operates through three segments: Pharmaceuticals, Vaccines and Consumer Healthcare. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases.
Receive News & Stock Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related stocks with our FREE daily email newsletter.